Use este identificador para citar ou linkar para este item: http://repositorio.ufc.br/handle/riufc/8458
Registro completo de metadados
Campo DCValorIdioma
dc.contributor.authorRodrigues, Francisco A. P.-
dc.contributor.authorPrata, Mara M. G.-
dc.contributor.authorOliveira, Iris Cristina Maia-
dc.contributor.authorAlves, Natacha Teresa Queiroz-
dc.contributor.authorFreitas, Rosa E. M.-
dc.contributor.authorMonteiro, Helena S. A.-
dc.contributor.authorSilva, Jame's A.-
dc.contributor.authorVieira, Paulo C.-
dc.contributor.authorViana, Daniel A.-
dc.contributor.authorLibório, Alexandre B.-
dc.contributor.authorHavt, Alexandre-
dc.date.accessioned2014-07-15T12:11:18Z-
dc.date.available2014-07-15T12:11:18Z-
dc.date.issued2014-04-
dc.identifier.citationRODRIGUES, F. A. P. et al. Gingerol fraction from zingiber officinale protects against gentamicin-induced nephrotoxicity. Antimicrobial agents and chemotherapy, Bethesda, v. 58, n. 4, p. 1872–1878, 2014.pt_BR
dc.identifier.issn1098-6596 On line-
dc.identifier.urihttp://www.repositorio.ufc.br/handle/riufc/8458-
dc.description.abstractNephrotoxicity is the main complication of gentamicin (GM) treatment. GM induces renal damage by overproduction of reactive oxygen species and inflammation in proximal tubular cells. Phenolic compounds from ginger, called gingerols, have been demonstrated to have antioxidant and anti-inflammatory effects. We investigated if oral treatment with an enriched solution of gingerols (GF) would promote a nephroprotective effect in an animal nephropathy model. The following six groups of male Wistar rats were studied: (i) control group (CT group); (ii) gingerol solution control group (GF group); (iii) gentamicin treatment group (GM group), receiving 100 mg/kg of body weight intraperitoneally (i.p.); and (iv to vi) gentamicin groups also receiving GF, at doses of 6.25, 12.5, and 25 mg/kg, respectively (GM GF groups). Animals from the GM group had a significant decrease in creatinine clearance and higher levels of urinary protein excretion. This was associated with markers of oxidative stress and nitric oxide production. Also, there were increases of the mRNA levels for proinflammatory cytokines (tumor necrosis factor alpha [TNF- ], interleukin-1 [IL-1 ], IL-2, and gamma interferon [IFN- ]). Histopathological findings of tubular degeneration and inflammatory cell infiltration reinforced GM-induced nephrotoxicity. All these alterations were attenuated by previous oral treatment with GF. Animals from the GM GF groups showed amelioration in renal function parameters and reduced lipid peroxidation and nitrosative stress, in addition to an increment in the levels of glutathione (GSH) and superoxide dismutase (SOD) activity. Gingerols also promoted significant reductions in mRNA transcription for TNF- , IL-2, and IFN- . These effects were dose dependent. These results demonstrate that GF promotes a nephroprotective effect on GM-mediated nephropathy by oxidative stress, inflammatory processes, and renal dysfunction.pt_BR
dc.language.isoenpt_BR
dc.publisherAntimicrobial Agents and Chemotherapypt_BR
dc.subjectGentamicinaspt_BR
dc.titleGingerol fraction from zingiber officinale nephrotoxicity protects against gentamicin-Induced nephrotoxicitypt_BR
dc.typeArtigo de Periódicopt_BR
Aparece nas coleções:DFIFA - Artigos publicados em revista científica

Arquivos associados a este item:
Arquivo Descrição TamanhoFormato 
2014_art_ntqalves.pdf1,02 MBAdobe PDFVisualizar/Abrir


Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.